Heteroplasmic ratio of the A3243G mitochondrial DNA mutation in single pancreatic beta cells

被引:50
作者
Lynn, S
Borthwick, GM
Charnley, RM
Walker, M
Turnbull, DM
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[3] Freeman Rd Hosp, Dept Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
基金
英国惠康基金;
关键词
mitochondrial DNA; A3243G mutation; pancreatic beta cells;
D O I
10.1007/s00125-002-1018-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Hypothesis. To examine whether there is a high content of mutated mitochondrial DNA in individual pancreatic beta cells from a patient with the A3243G mitochondrial DNA mutation. Methods. Tissues were available from a patient with diabetes and the A3243G mutation including pancreatic tissue. We quantified the amount of mutated mitochondrial DNA in tissue homogenates and single pancreatic beta cells using hot last cycle PCR. Results. The percentage ratio of mutated to wild-type mtDNA was high in tissues such as muscle and brain (>60%), but surprisingly low in both pancreatic islets and in individual beta cells from these islets. The islets were smaller in the patient than in control subjects in keeping with a decreased beta-cell mass. Conclusions/interpretation. These observations suggest that either the beta cells show increased sensitivity to the effects mtDNA mutations on respiratory chain function, and/or cells with a high mutant load are preferentially removed leading to a progressive decrease in the islet beta-cell mass.
引用
收藏
页码:296 / 299
页数:4
相关论文
共 12 条
[1]  
Chinnery PF, 1999, AM J MED GENET, V85, P498
[2]  
Chinnery PF, 2000, ANN NEUROL, V47, P381, DOI 10.1002/1531-8249(200003)47:3<381::AID-ANA17>3.3.CO
[3]  
2-U
[4]   In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243 [J].
Kobayashi, T ;
Nakanishi, K ;
Nakase, H ;
Kajio, H ;
Okubo, M ;
Murase, T ;
Kosaka, K .
DIABETES, 1997, 46 (10) :1567-1571
[5]   Molecular and clinical aspects of mitochondrial diabetes mellitus [J].
Maassen, JA ;
van Essen, E ;
van den Ouweland, JMW ;
Lemkes, HHJP .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 (03) :127-134
[6]   Mitochondrial function in normal and diabetic β-cells [J].
Maechler, P ;
Wollheim, CB .
NATURE, 2001, 414 (6865) :807-812
[7]   Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion [J].
Otabe, S ;
Yasuda, K ;
Mori, Y ;
Shimokawa, K ;
Kadowaki, H ;
Jimi, A ;
Nonaka, K ;
Akanuma, Y ;
Yazaki, Y ;
Kadowaki, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (01) :149-156
[8]   EXTREMELY HIGH-LEVELS OF MUTANT MTDNAS CO-LOCALIZE WITH CYTOCHROME-C OXIDASE-NEGATIVE RAGGED-RED FIBERS IN PATIENTS HARBORING A POINT MUTATION AT NT-3243 [J].
PETRUZZELLA, V ;
MORAES, CT ;
SANO, MC ;
BONILLA, E ;
DIMAURO, S ;
SCHON, EA .
HUMAN MOLECULAR GENETICS, 1994, 3 (03) :449-454
[9]  
Sciacco M, 1998, MUSCLE NERVE, V21, P1374, DOI 10.1002/(SICI)1097-4598(199811)21:11<1374::AID-MUS3>3.0.CO
[10]  
2-6